Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SAR analysis of Antagonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay - Set 2
Assay data:1 Active, 20 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
An siRNA screen for human genes that are involved in human papilloma virus (HPV) E2 transcriptional repression of the E6 and E7 oncogenes
Assay data:497 Active, 21019 Tested
SummaryPubMed Citation
Late-stage radioligand binding dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen Ki Set 2
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late-stage radioligand binding assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen Set 2
Assay data:1 Active, 1 Tested
SAR analysis of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 6
Assay data:12 Active, 6 Activity ≤ 1 µM, 18 Tested
SAR analysis of Antagonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay - Set 4
Assay data:30 Active, 21 Activity ≤ 1 µM, 44 Tested
SAR analysis of Agonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay-Set 3
Assay data:20 Active, 5 Activity ≤ 1 µM, 34 Tested
SAR analysis of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 5
Assay data:8 Active, 1 Activity ≤ 1 µM, 11 Tested
SAR analysis of Antagonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay - Set 3
Assay data:24 Active, 16 Activity ≤ 1 µM, 42 Tested
SAR analysis of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 4
Assay data:18 Active, 4 Activity ≤ 1 µM, 34 Tested
SAR analysis of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 3
Assay data:35 Active, 5 Activity ≤ 1 µM, 66 Tested
SAR analysis of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 3
Assay data:33 Active, 10 Activity ≤ 1 µM, 59 Tested
Late-stage radioligand binding assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen
SAR analysis of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 2
Assay data:14 Active, 6 Activity ≤ 1 µM, 24 Tested
SAR analysis of Agonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay - Set 2
Assay data:8 Active, 2 Activity ≤ 1 µM, 16 Tested
SAR analysis of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 2
Assay data:1 Active, 5 Tested
Late stage results from the probe development efforts to identify dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and nuclear factor NF-kappa-B (NF-kB): Cell-based radioligand binding assay to determine the binding affinities for selected transporters, receptors, and GPCRs
SAR analysis of Agonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay
Assay data:21 Active, 8 Activity ≤ 1 µM, 62 Tested
SAR analysis of Antagonists of the Kappa Opioid Receptor (KOR) using an Image-Based Assay
Assay data:11 Active, 4 Activity ≤ 1 µM, 62 Tested
SAR analysis of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay
Assay data:12 Active, 2 Activity ≤ 1 µM, 32 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on